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Background: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an
important role in health and disease in the host. Several factors can cause disruption of the normal intestinal
microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to
characterize changes in the fecal bacterial populations of healthy horses associated with the administration of
frequently used antimicrobial drugs.
Results: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium
IM, trimethoprim sulfadiazine (TMS) orally or to a control group. Treatment was given for 5 consecutive days and
fecal samples were collected before drug administration (Day 1), at the end of treatment (Days 5), and on Days 14
and 30 of the trial. High throughput sequencing of the V4 region of the 16S rRNA gene was performed using an
Illumina MiSeq sequencer. Significant changes of population structure and community membership were observed
after the use of all drugs. TMS caused the most marked changes on fecal microbiota even at higher taxonomic
levels including a significant decrease of richness and diversity. Those changes were mainly due to a drastic
decrease of Verrucomicrobia, specifically the “5 genus incertae sedis”. Changes in structure and membership caused
by antimicrobial administration were specific for each drug and may be predictable. Twenty-five days after the end
of treatment, bacterial profiles were more similar to pre-treatment patterns indicating a recovery from changes caused
by antimicrobial administration, but differences were still evident, especially regarding community membership.
Conclusions: The use of systemic antimicrobials leads to changes in the intestinal microbiota, with different and
specific responses to different antimicrobials. All antimicrobials tested here had some impact on the microbiota, but
TMS significantly reduced bacterial species richness and diversity and had the greatest apparent impact on population
structure, specifically targeting members of the Verrucomicrobia phylum.
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The intestinal microbiota performs important roles in
the maintenance of health and on the pathophysiology
of several diseases [1]. In the horse, the intestinal bacterial
microbiota is particularly important due to its role in cel-
lulose fermentation and short chain fatty acid production,
which comprise the main energy sources for this animal
species [2]. Gastrointestinal disease is one of the leading
causes of morbidity and mortality in the horse [3], yet,
despite its importance, the equine intestinal microbiota
has not been extensively investigated. However, new* Correspondence: costamc@gmail.com
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quencing methods, have become more available of late,
and recently a number of publications have brought
new insights into this complex microbial community
[4-9]. Yet, much about the equine intestinal microbiota
remains to be discerned.
Several factors have been shown to induce profound
changes on the gastro-intestinal microbiota of horses
including diet [10,11], intestinal disease [5], fasting [12,13]
and transportation [14]. Of special interest are the effects
of antimicrobials, as this group of drugs can have major
impact on the intestinal microbiota of horses [15], and
colitis is an important (and potentially life-threatening)
complication of antimicrobial exposure in this species
[16-18].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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use of antibiotics can be present as soon as 24 hours
after administration of the drug in humans, with pro-
found changes around 4 days [19,20] and partial recov-
ery of the intestinal microbiota occurring around 30 to
40 days after treatment [19,21,22]. However, structural
changes in bacterial communities may take years to
return to pre-treatment baseline following antibiotic
induced disturbance [23].
To date, many investigations of the effects of anti-
microbial usage in horses have been limited to culture-
based studies [15,24,25], which have yielded conflicting
results. Gustafsson et al. [25] found no effect on the
fecal microbiota of horses treated with oral or intra-
venous trimethoprim-sulfadiazine (TMS). Conversely,
Harlow et al. [15] showed dramatic disruption of the
culturable microbiota concurrent with increased shed-
ding of enteropathogens after administration of TMS
or ceftiofur sodium in horses. Moreover, a study using
DGGE failed to detect changes caused by the use of an-
tibiotics [26]; however, it is unclear whether there was
no true difference or whether results simply reflect the
limited resolution of this technique. While culture-
dependent methods are necessary to characterize new
bacterial species and can give better resolution for the
identification of microorganisms, sequencing methods have
become the elective choice for a broader characterization
of the intestinal microbiota.
The objective of this study was to evaluate changes in
the intestinal microbiota of healthy horses in response to




A total of 4,275,413 reads from 96 samples (mean:
47,431; SD: 29,796) passed all quality filters and were
assigned into operational taxonomic units (OTUs). A
subsample of 10.482 reads per sample was taken in order
to normalize the number of reads across all samples and
six samples were excluded from analysis because of low
read numbers. These belonged to the groups: penicillin
(Day 30), TMS (Day 1: two samples and Day 14: two
samples) and control (Day 5). The number of OTUs in
the subsampled population varied between 1,333 and
3,628 per sample (mean: 2,671; SD: 488). The number of
OTUs found in each sample is presented in Additional
file 1.
The average of the number of reads found in each
group after subsampling of 10,000 reads is represented
by rarefaction curves in Figure 1. Results from the
Good’s coverage achieved after subsampling are presented
in Additional file 1 (mean: 85%; SD: 4%) and are also
supportive of good coverage.Relative abundances
The relative abundances at the phylum, class and genus
levels found in each group at the different sampling
times are represented in Figure 2. Sequences were classi-
fied into 25 different phyla, of which, only eight accounted
for more than 1% of sequences. The majority of bacteria
found in all groups throughout the trial were assigned to
the Firmicutes phylum. Verrucomicrobia represented the
second main phylum, followed by bacteria that were un-
classified at the phylum level. At the genus level, “5 genus
incertae sedis”, a genus from the Subdivision 5 class of the
Verrucomicrobia phylum, predominated followed by bac-
teria unclassified at the phylum level. Figure 3 represents
variation of the main genera overtime in each treatment
group.
No statistical changes in relative abundances were
observed at the phylum level in response to ceftiofur
administration. A decrease of Spirochetes followed by
a significant increase on Day 14 (P = 0.017) was observed
after treatment with penicillin. Oral TMS significantly
reduced the relative abundance of Verrucomicrobia
(P = 0.012), unclassified bacteria (P = 0.025) and a trend to
reduce Proteobacteria (P = 0.052) and increased the abun-
dance of Firmicutes (P = 0.012) after 5 days of treatment.
Population analysis
Results of Simpson’s index estimating samples’ diversity,
and of Catchall estimation of richness are presented in
Additional file 1. Table 1 contains results from the com-
parison of those results at different sampling times within
each group. There was a significant decrease in richness
(P = 0.017) and diversity (P = 0.018) after the use of TMS
(Day 1 × Day 5), but after 30 days, both estimates were
similar to the beginning of the trial. No other differences
in diversity or richness were identified.
Figures 4A and B represent the dendrograms obtained
with the Yue and Clayton and the Classic Jaccard analyses
that respectively represent population structure (taking
into account the number of OTUs and their relative
abundances) and community membership (taking into
account the number of OTUs). Figure 4A indicates
that samples collected before treatment had more
similar microbial population structure to each other
and to samples collected on Day 14 and 30. In general,
samples collected after treatment (Day 5) are observed
at the lower part of the tree and interestingly, samples
tended to cluster by the drug administered, indicating
a somewhat consistent effect of each antibiotic, with the
exception of animals treated with penicillin. Conversely,
penicillin and ceftiofur seemed to have a strong effect on
community membership, as represented by Figure 4B, in
which samples from animals receiving those drugs were
more distinct from other samples, even at Day 14. The
changes caused by TMS and ceftiofur administration on
Figure 1 Rarefaction curves representing the average number of OTUs (y axis) by the number of reads (x axis).
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ples after drug administration (Day 5) tended to cluster
together.
Results from the Parsimony and AMOVA tests com-
paring each group at the different sampling times for ei-
ther population structure and community membership
are presented in Table 1. Overall, population structure
and community membership were significantly different
after the use of antimicrobials, regardless of the statis-
tical test applied. The results also indicate that after 14
and 30 days population structures were still different
from the beginning of the trial. Considering each group
individually, penicillin had no impact on population
structure and community membership evaluated by the
Parsimony test, but a significant difference was identified
using AMOVA. Ceftiofur and TMS induced significant
changes 5 days after drug administration, but changes
tended not to last for more than 14 days, indicating a re-
covery of population structure and community member-
ship in the studied animals.
The graphical representation of the PCoA is shown in
Figure 5A and B, for the Yue and Clayton and the Classic
Jaccard respectively. Despite the two first axes of the
PCoA explained only 28% and 3.7% of the dissimilarities
between samples respectively for the Yue and Clayton andthe Classic Jaccard, clustering of samples by date of sam-
pling and by drug administered is still evident, reinforcing
the strong impact caused by antibiotics administration on
the intestinal microbiota of those animals, which is further
supported by the significant results from the AMOVA test
(Table 1).
Potential confounding factors
A moderate lameness was noticed in one mare in the
penicillin group on Day 4 of the trial due to a sole ab-
scess on the right front limb. The mare was transported
(approximately 10 km) to the Ontario Veterinary College
Health Sciences Centre (OVCHSC) after collection of
the Day 5 sample and the last antimicrobial treatment
was given at the hospital. The diet of that horse was un-
changed (with the exception of feeding from a different
batch of hay). Treatment with 2 g of phenylbutazone
was given and the mare returned to the research station
on Day 9. Another dose of phenylbutazone was given on
Day 15, as the mare became mildly lame again. On Day
22 of the trial, another mare from the ceftiofur group
was found with a deep laceration on her chest and was
therefore shipped to the OVCHSC for treatment. Cleaning
with topical antiseptic solution was started with no sys-
temic antimicrobials required. The mare recovered well
Figure 2 Relative abundance of predominant bacteria at the phylum (A), class (B) and genus (C) levels. Figure legend: penicillin (PEN),
ceftiofur (CEF) and sulfa trimethoprin (TMS) and control group (CON). Day 0: before treatment; Day 5: last day of treatment.
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Figure 3 Variation in relative abundance of predominant
bacteria in feces of healthy horses treated with antibiotics.
Figure legend: A: penicillin; B: ceftiofur; C: sulfa trimethoprin; D:
control group. Day 0: before treatment; Day 5: last day of treatment.
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trial.
Discussion
Antimicrobial administration produced variable but
detectable changes in the fecal microbiota. Differences
were noted in specific taxonomic comparisons as well
as broader evaluation of community membership (or-
ganisms present) and population structure (that takes
into account the organisms present and their relative
abundances). The presence of an impact of antimicrobial
administration of a bacterial population is not unexpected,
but the types of changes, the differences between different
antimicrobials and the duration of impact are noteworthy
and provide important insight.
The composition of the microbiota before antibiotic
administration was not surprising, as the predominance of
Firmicutes is in agreement with other studies [5,6,8,9].
The “5 genus incertae sedis” was the most abundant
genus. This unculturable organism has been recently clas-
sified and it has been found in high abundances in feces of
healthy adult horses [8,9], but its role on the equine GI
tract remains to be elucidated.
The most profound effects of antimicrobials on the
intestinal microbiota were observed immediately after
treatment (Day 5), which is in agreement with reports
in humans [20,27] and horses [15]. It was not surprising
to see the main effect during antimicrobial treatment.
Cessation of antimicrobial administration did not result in
an immediate return to the baseline microbiota, as signifi-
cant changes were still present 9 days after the end of
treatment (Day 14). A similar effect has been previously
observed after the use of ampicillin in humans [22] and of
TMS or ceftiofur in horses [15]. By day 30 the microbiota
was more similar to baseline than it was in the day 5 or
day 14 samples, yet a discernable difference was still
present, also evidenced by the significantly different
AMOVA comparison in the group treated with penicil-
lin (P = 0.021) and a trend in the group treated with
TMS (P = 0.066). Immediate restoration of the microbiota
was not expected, based on human data [21,22,27]. There
was also limited apparent clustering of the day 1 and day
30 samples in the treatment group based on the dendro-
grams, as opposed to the control group, but further statis-
tical comparison were not possible due to the low number
of animals in the control group.It is assumed that there is
more inter- than intra-individual variation and serial sam-
ples from the same individual typically cluster together
Table 1 P values from the Parsimony, AMOVA and t tests
comparing groups at different sampling times
Treatment Day 1- 5 Day 5- 14 Day 14- 30 Day 1- 14 Day 1- 30
Yue and Clayton
Overall
Parsimony <0.001 <0.001 0.137 0.005 0.053
AMOVA <0.001 <0.001 <0.001 0.060 <0.001
Penicillin
Parsimony 0.263 0.052 0.865 0.059 0.114
AMOVA 0.042 0.010 0.272 0.141 0.021
Ceftiofur
Parsimony 0.004 0.065 0.704 0.305 0.298
AMOVA 0.786 0.038 0.024 0.786 0.141
TMS
Parsimony 0.002 <0.001 0.214 0.858 0.674
AMOVA <0.001 0.002 0.028 0.119 0.066
Control
Parsimony 1 1 1 1 1
AMOVA 1 1 1 1 1
Jaccard
Overall
Parsimony <0.001 0.003 0.753 0.068 0.054
AMOVA <0.001 <0.001 0.007 <0.001 <0.001
Penicillin
Parsimony 0.063 0.714 0.836 0.698 0.408
AMOVA <0.001 0.012 0.669 0.172 0.260
Ceftiofur
Parsimony <0.001 <0.001 0.701 0.281 0.683
AMOVA <0.001 0.006 0.140 0.037 0.074
TMS
Parsimony <0.001 <0.001 0.682 0.878 0.67
AMOVA 0.003 0.003 0.033 0.025 0.096
Control
Parsimony 1 1 1 1 1
AMOVA 1 1 1 1 1
t test
Penicillin
Simpson’s 0.181 0.898 0.607
CatchAll 0.163 0.172 0.794
Ceftiofur
Simpson’s 0.628 0.370 0.321
CatchAll 0.385 0.068 0.206
TMS
Simpson’s 0.018 0.008 0.876
CatchAll 0.017 0.002 0.508
Table 1 P values from the Parsimony, AMOVA and t tests
comparing groups at different sampling times (Continued)
Control
Simpson’s 0.400 0.554 0.495
CatchAll 0.278 0.680 0.266
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dent. Here, the lack of clustering of day 1 and 30 samples
from the same horse provides further evidence of an
ongoing impact of antimicrobials. This provides more
evidence of an ongoing impact on the microbiota, as
intra-individual similarity would be expected in serial
samples if the microbiota had reverted to its baseline.
Among the antimicrobials chosen for this study, TMS
induced the most marked changes in population structure.
Possible reasons for this are the route of administration
used for this drug (oral) and its broader spectrum of ac-
tion, especially when compared to penicillin, which has a
narrower spectrum and is mainly excreted by the urinary
tract. Oral administration can result in delivery of a large
amount of active drug to the intestinal tract; however, the
degree of absorption and local inactivation would have a
major impact on exposure to the microbiota of the distal
hindgut. Conversely, parenterally administered drugs can
potentially achieve high intestinal concentrations, par-
ticularly those that undergo extensive hepatic excretion.
Indeed, several classes of antimicrobials have been shown
to induce changes on the luminal bacteria after intra-
muscular administration [29,30] and some of the horses
receiving penicillin and ceftiofur in this study had marked
changes observed on community membership (Figure 4B).
It is worth mentioning that the dose of ceftiofur sodium
used in this study is an extra-label dose, but it was used as
it reflects common dosing in the field. Further studies
comparing oral versus parenteral administration of TMS
would help answer the question of whether changes ob-
served here were induced by route of administration or by
the spectrum of action of this drug.
Factors such as the antimicrobial spectrum, drug levels
in the gut and inactivation of the antimicrobial in the
gut could all influence the impact of individual antimicro-
bials. TMS is one of the few drugs that horses tolerate
after oral administration, and it is also available as a paren-
teral formulation, so comparison of the parenteral and
oral routes would be useful in a future study to determine
the impact of route of administration of this drug.
While TMS produced the most identifiable impacts,
some degree of change was noted with all of the tested
antimicrobials. A lack of understanding of the pathophysi-
ology of antimicrobial-associated colitis and the clinical
relevance of the gut microbiota hamper direct clinical as-
sessment of the relevance of these changes. It is reason-
able to postulate that more profound microbiota changes
Figure 4 Dendrograms representing the similarities between
population structure addressed by the Yue and Clayton
analysis (A) and community membership addressed by the
Classic Jaccard (B). Figure legend: Dendrograms were generated
based on phylip-formatted distance matrixes using the UPGMA
algorithm. The number after the name of the horse represents the
day of sampling and the color of the tree brunch represents the
drug used: Penicillin = blue, Ceftiofur = green, TMS = red and
Control = black.
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relevant change’ are not necessarily the same thing, and it
is certainly possible that some less evident changes could
be more relevant clinically. This highlights the need for
more study of the intestinal microbiota in health and
disease, to identify specific populations or population
changes that have a greater influence.
The methods used in the present study allowed for dif-
ferentiation between population structure addressed by
the Yue and Clayton measure of dissimilarity that takes
into account relative abundance in each sample and
community membership addressed by the classic Jaccard
index that takes into account the number of species.
Interestingly, as it can be observed on the dendrograms,
there was greater alteration of population structure
compared to community membership. Thus, changes
that were encountered were less likely to be addition or
loss of specific community members, but rather changes
in the relative abundance of existing members. This is
consistent with the concept of ‘overgrowth’ of certain
members in response to antimicrobial exposure.
Significant changes in the relative abundances at the
phylum level observed in horses treated with penicillin
and especially TMS, emphasize the potential those drugs
have in causing disruption of the normal resident intes-
tinal microbiota. Interestingly, the dramatic decrease
(from 21.2% to 0.8%) of organisms classified as “5 genus
incertae sedis” and unclassified Verrucomicrobia after
the used of TMS is suggestive that this drug has a strong
action against Verrucomicrobia, which allowed several
genera belonging to Firmicutes to increase in abundance
and it may be related to the resilience of the intestinal
microbiota during recovery from severe disturbances
[31]. The degree of change noted here is in contrast with
earlier culture-dependent or DGGE studies, something
that is not surprising because of the much greater depth
that high throughput sequencing technologies allow. For
instance, Gustafsson et al. [25] reported minimal effect
of TMS on streptococci, Bacteroides and Veillonella
counts in feces of horses, with a concurrent decrease in
total coliforms. White and Prior [24] found no impact of
this drug in coliforms, but a large increase of coliforms,
Bacteroides, Clostridium perfringens, and streptococci after
treatment with oxytetracycline. Moreover, Grønvold et al.
Figure 5 (See legend on next page.)
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Figure 5 Principal coordinate analysis (PCoA) of bacterial communities present in feces of horses treated with antibiotics. Figure
legend: Bidimentional representation of the principal coordinate analysis of bacterial communities structure addressed by the Yue and Clayton
analysis (A) and bacterial membership addressed by the Classic Jaccard analysis (B) found in feces of healthy horses before (Day 1), after (Day 5)
treatment with antibiotics and at Days 14 and 30.
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of horses after treatment with penicillin, but differences in
specific bacterial groups were present in the same study
when investigated by qPCR. Therefore, the conflicting re-
sults found in the literature may reflect differences based
on drugs used, horse characteristics or geography, but
are more likely a result of variable fidelity of the chosen
methods.
Conflicting results can be found in the literature re-
garding the predictability of changes induced by specific
antimicrobial drugs. Vancomycin has been reported to
induce consistent changes on intestinal microbial struc-
tures of humans treated with that drug [32], but another
study reported unpredictable changes caused by the same
drug [33]. Another report [27] found different individual
responses to antimicrobial therapy despite identical dos-
ing. This disagreement might be related to the presence of
other factors impacting the intestinal microbiota in those
subjects. Further, since there tends to be some variability
in the microbiota between individuals, it is possible that
some individual microbiotas are more or less susceptible
to alteration by individual antimicrobials. This study used
horses that were co-housed, fed an identical diet and with
other management similarities (e.g. exercise, environmen-
tal exposures), something that might minimize the inter-
individual variability.
A few limitations must be considered. While consistent
with many other microbiota studies, the sample size was
low, which may have affected the ability to identify certain
differences through limitations in statistical power. How-
ever, numerous changes were still identified. Also, we used
a carefully controlled population in order to minimize
other effects on the gut microbiota of these horses; there-
fore, caution is required for the extrapolation of our re-
sults to horses managed differently or living in different
regions. In addition, it would have been interesting to con-
tinue to sample the horses in our cohort for a longer
period to see when, or if, the microbiota would return to
‘normal’ for the individual animals. Finally, despite the fact
that fecal microbiota have been suggested to represent the
microbiota present in the large colon of horses [6], use of
fecal samples may limit the study of changes occurring in
more proximal compartments of the GI tract.
Conclusions
The use of systemic antimicrobials leads to changes in the
intestinal microbiota, with different and specific responses
to different antimicrobials. All antimicrobials tested herehad some impact on the microbiota, but TMS significantly
reduced bacterial richness and diversity and had the great-
est apparent impact on bacterial structures, specifically
targeting members of the Verrucomicrobia phylum.
Methods
Animal selection
Twenty-one healthy adult horses and three ponies with
no history of gastrointestinal diseases or antimicrobial
administration during the previous six months were
enrolled. The animals were kept on pasture and fed
grass hay twice a day. All horses received hay from the
same batch throughout the trial and were moved into a
pen 5 days before the beginning of the trial for
acclimatization. Seven horses were randomly assigned
to each of three treatment groups that received
procaine penicillin (20.000 UI/kg intramuscularly (IM),
q12h (Pen Aqueous®, Wyeth, ON, Canada)), ceftiofur
sodium (2.2 mg/kg IM, q12h (Excenel® Pfizer Animal
Health, QC, Canada)) or trimethoprim sulfadiazine (TMS)
(30 mg/kg orally, q12h (Uniprim Powder®, Macleod Phar-
maceuticals Inc., CO, USA)) for 5 days. The sites of intra
muscular injections were alternated with a maximum
volume of 20 mL per site. Trimethoprim sulfadiazine
was mixed with approximately 20 mL of warm corn
syrup in order facilitate administration. Three individ-
uals (one pony, one Belgian and one Thoroughbred)
were assigned to the control group, which received no
antimicrobials. The date of sampling, breed, age and
treatment given for each horse used for the trial are pre-
sented in Table 2.
Fecal samples were collected by rectal palpation using
one rectal sleeve per animal. Samples were stored in plas-
tic sterile containers and frozen at −80°C within 2 hours
after collection until DNA extraction. Samples were col-
lected before drug administration (Day 1), on the third
and fifth day of treatment and again on Days 7, 14, 23 and
30 after the onset of treatment.
Table 2 lists the breed, group of treatment and dates
when the trial was performed in each group. The study
was approved by the University of Guelph Animal Care
Committee.
DNA extraction, 16S rRNA gene PCR and sequencing
DNA extraction was performed using a commercial kit
(E.Z.N.A. Stool DNA Kit, Omega Bio-Tek Inc., USA)
following the manufacturer’s “stool DNA protocol for
pathogen detection”.
Table 2 Breed, age, treatment group, and date of sampling of each studied horse
Breed Year of birth Treatment Date
Anne Standardbred 2006 Pen Nov 12 – Dec 12
Betty Standardbred 2003 Pen Oct 9 -Nov 8
Daphne Standardbred 2000 Pen Sep 4 – Oct 4
Gertrude Standardbred 2006 Pen Sep 4 – Oct 4
Jenny Standardbred 2000 Pen Sep 4 – Oct 4
Paige Standardbred 2003 Pen Nov 12 – Dec 12
Tia Pony 2006 Pen Sep 4 – Oct 4
Autumn Pony 2006 Ceftio Sep 4 – Oct 4
Butter Cup Standardbred 2003 Ceftio Sep 4 – Oct 4
Dragon Standardbred 2003 Ceftio Sep 4 – Oct 4
India Thoroughbred 1996 Ceftio Sep 4 – Oct 4
Jackie Standardbred 2007 Ceftio Oct 9 -Nov 8
Lauryn Standardbred 2004 Ceftio Nov 12 – Dec 12
Lucky Standardbred 2001 Ceftio Nov 12 – Dec 12
Beauty Standardbred 2004 TMS Nov 12 – Dec 12
Fire Standardbred unknown TMS Oct 9 -Nov 8
Finch Standardbred 1999 TMS Oct 9 -Nov 8
Iris Standardbred 2004 TMS Nov 12 – Dec 12
Lilly Belgian/Paint 2005 TMS Nov 12 – Dec 12
Lovie Standardbred 1997 TMS Oct 9 -Nov 8
Missy Standardbred unknown TMS Oct 9 -Nov 8
Daisy Belgian/Paint 2005 Control Nov 12 – Dec 12
Jane Standardbred 2002 Control Sep 4 – Oct 4
Jersey Pony 2005 Control Sep 4 – Oct 4
Costa et al. BMC Veterinary Research  (2015) 11:19 Page 10 of 12PCR amplification of the V4 region of the 16S rRNA
gene was designed based on Klindworth et al. [34] study
using the primers forward S-D-Bact-0564-a-S-15 (5′-AY
TGGGYDTAAAGNG-3′) and reverse S-D-Bact-0785-b-
A-18 (5′-TACNVGGGTATCTAATCC-3′). The forward
and reverse primers were designed containing an over-
lapping region of the forward and reverse Illumina se-
quencing primers (TCGTCGGCAGCGTCAGATGTGT
ATAAGAGACAG and GTCTCGTGGGCTCGGAGAT
GTGTATAAGAGACAG, respectively) in order to anneal
them to primers containing the Illumina adaptors plus the
8 bp identifiers indices (AATGATACGGCGACCACCG
AGATCTACAC-index-TCGTCGGCAGCGTC forward
and CAAGCAGAAGACGGCATACGAGAT-index-GT
CTCGTGGGCTCGG reverse). For a final volume of
50 μL, 2 μL of each DNA sample was added to a solu-
tion containing 18.7 μL of water, 25 μL of Fast HotStart
ReadyMix 2X (KapaBiosystems, USA), 1.3 μL of BSA
(Invitrogen, USA), and 0.5 μL of each 16S primer and
1 μL of each Illumina primers (100 pmol/μL). The mix-
ture was subjected to the following PCR conditions:
5 min at 94°C for denaturing, and 25 cycles of 30 sec at94°C for denaturing, 30 sec at 46°C for annealing and
30 sec at 72°C for elongation followed by a final period
of 7 min at 72°C and kept at 4°C until purification.
PCR products were evaluated by electrophoresis in 2%
agarose gel and purified with the Agencourt AMPure
XP (Beckman Coulter Inc, Mississauga, ON) by mixing
22 μL of amplicon with 72 μL of AMPure on a 96 well
plate. After 5 min at room temperature, beads were sep-
arated and washed twice with 80% ethanol and eluted in
30 μL of water. After purification samples were quanti-
fied by spectrophotometry using the NanoDrop® (Roche,
USA) and normalized to a final concentration of 2 nM.
The library pool was sequenced with an Illumina MiSeq
for 250 cycles from each end at the University of Guelph
Genomics Facility.
Data was made publicly available at the NCBI Sequence
Read Archive under the accession number PRJNA264726.
Sequence analysis and statistical analysis
Bioinformatic analysis was performed using the Mothur
(version 1.31.2) package of algorithms [35] following the
MiSeq SOP accessed in January 2014 [36]. Briefly, original
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were longer than 275 bp in length, contained any ambigu-
ous base pairs or had runs of homopolymers greater than
8 bp were removed. Sequences were aligned using the
SILVA 16S rRNA reference database [37]. Chimeras were
identified and removed using uchime [38]. Sequences
were then assigned into operational taxonomic units
(OTUs) using a cutoff of 0.03 for the distance matrix and
into phylotypes by clustering all sequences belonging to
the same genus. Taxonomic classification was obtained
from the Ribosomal Database Project (RDP – March
2012) [39].
A subsample from the main dataset was used for rich-
ness and diversity calculation in an attempt to decrease
bias caused by non-uniform sequence depth and some
low sequence number samples. The minimum number
of reads that would not compromise coverage and would
eliminate the fewest samples as possible from the analysis
was used (10.482 reads per sample). Good’s coverage after
sub-sampling was calculated in order to ensure represen-
tative sub-samples. Diversity was estimated by the inverse
Simpson diversity index and richness by using CatchAll
[40]. Comparison among groups was performed using a t-
test. Sampling effort was evaluated by calculation of Good’s
coverage and visual assessment by rarefaction curves.
The dissimilarity between groups was measured by a
phylip-formated distance matrix using the Yue & Clayton
measure of dissimilarity (taking into account the relative
abundance of OTUs present in each group: population
structure) and the classical Jaccard index (taking into ac-
count the number of shared OTUs between the groups:
community membership). Dendrograms comparing the
similarity of the bacterial profiles among all samples were
generated using the Jaccard index and Yue & Clayton
measures and figures were generated using FigTree (ver-
sion 1.4.0). Population membership and structure present
in the dendrograms were compared by the parsimony test.
Clustering of samples was evaluated by plotting the
resultant vector of the Principal Coordinate Analysis
(PCoA) with 2 dimensions. Analysis of molecular vari-
ance (AMOVA) was used to determine significance of
clustering between the groups.
Bar charts representing the relative abundance at the
phylum, class and genus levels of each group at the dif-
ferent sampling times were generated for visualization of
population structure and relative abundances were com-
pared at the different sampling times by the Steel-Dwass
test controlling for multiple comparison error.Additional file
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